Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 5/2018

01-10-2018 | Short Research Report

Assessment of polypharmacy in elderly patients by using data from dispensed medications in community pharmacies: analysis of results by using different methods of estimation

Authors: Luciana Carla Chiapella, Jorgelina Montemarani Menna, María Eugenia Mamprin

Published in: International Journal of Clinical Pharmacy | Issue 5/2018

Login to get access

Abstract

Background Estimating the prevalence of polypharmacy is essential for the evaluation of public health. Many different methodologies are used to determine the number of drugs used by a patient. Objective To analyse and compare three different methods (simultaneous, cumulative and continuous medication) to determine the number of drugs used by a patient, to estimate the prevalence of polypharmacy and to evaluate the possible association between polypharmacy and the gender and age of patients. Method Cross-sectional observational study carried out between April and September 2015. Data were acquired from prescriptions corresponding to 3972 patients aged 65 years old or older in ten community pharmacies in Argentina. Results The prevalence of polypharmacy varied significantly according to the method used. Major polypharmacy (use of five or more drugs) was detected in 20.5–47.1% of the patients. The association between gender, age and polypharmacy was statistically significant only when using the continuous medication method. The prevalence of minor polypharmacy (use of two to four drugs) was similar with the three methods. Conclusion These results contribute to deciding which is the best method to determine polypharmacy according to the objective of future studies and considering the advantages and disadvantages of each of them.
Literature
1.
go back to reference Wade O. Concept of drug utilization studies. In: Bergman U, Grimsson A, Wahba A, Westerholm B, editors. Studies in drug utilization. Copenhagen: WHO Regional Office for Europe; 1979. p. 3–15. Wade O. Concept of drug utilization studies. In: Bergman U, Grimsson A, Wahba A, Westerholm B, editors. Studies in drug utilization. Copenhagen: WHO Regional Office for Europe; 1979. p. 3–15.
2.
go back to reference Goedken AM, Lund BC, Cook EA, Schroeder MC, Brooks JM. Application of a framework for determining number of drugs. BMC Res Notes. 2016;9(1):1–13.CrossRef Goedken AM, Lund BC, Cook EA, Schroeder MC, Brooks JM. Application of a framework for determining number of drugs. BMC Res Notes. 2016;9(1):1–13.CrossRef
3.
go back to reference Monégat M, Sermet C, Perronnin M, Rococo E. Polypharmacy: definitions, measurement and stakes involved review of the literature and measurement tests. Questions d’économie de la santé. 2014;214:1–8. Monégat M, Sermet C, Perronnin M, Rococo E. Polypharmacy: definitions, measurement and stakes involved review of the literature and measurement tests. Questions d’économie de la santé. 2014;214:1–8.
4.
go back to reference Bjerrum L, Sogaard J, Hallas J, Kragstrup J. Polypharmacy: correlations with sex, age and drug regimen. A prescription database study. Eur J Clin Pharmacol. 1998;54(3):197–202.CrossRef Bjerrum L, Sogaard J, Hallas J, Kragstrup J. Polypharmacy: correlations with sex, age and drug regimen. A prescription database study. Eur J Clin Pharmacol. 1998;54(3):197–202.CrossRef
6.
go back to reference WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2016. 19 ed. Oslo, Norway: 2015. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2016. 19 ed. Oslo, Norway: 2015.
7.
go back to reference Bjerrum L, Rosholm JU, Hallas J, Kragstrup J. Methods for estimating the occurrence of polypharmacy by means of a prescription database. Eur J Clin Pharmacol. 1997;53(1):7–11.CrossRef Bjerrum L, Rosholm JU, Hallas J, Kragstrup J. Methods for estimating the occurrence of polypharmacy by means of a prescription database. Eur J Clin Pharmacol. 1997;53(1):7–11.CrossRef
8.
go back to reference Marzi MM, Diruscio AV, Nunez HM, Pires SM, Quaglia BN. Analysis of medication prescription in an Argentinian Geriatric Hospital. Rev Med Chil. 2013;141(2):194–201.CrossRef Marzi MM, Diruscio AV, Nunez HM, Pires SM, Quaglia BN. Analysis of medication prescription in an Argentinian Geriatric Hospital. Rev Med Chil. 2013;141(2):194–201.CrossRef
9.
go back to reference Regueiro M, Mendy N, Cañás M, Farina HO, Nagel P. Uso de medicamentos en adultos mayores no institucionalizados. Rev Peru Med Exp Salud Publica. 2011;28:643–7.PubMed Regueiro M, Mendy N, Cañás M, Farina HO, Nagel P. Uso de medicamentos en adultos mayores no institucionalizados. Rev Peru Med Exp Salud Publica. 2011;28:643–7.PubMed
10.
go back to reference Hofer-Dueckelmann C. Gender and polypharmacotherapy in the elderly: a clinical challenge. In: Sex and Gender Differences in Pharmacology; 2013. p. 169–182. Hofer-Dueckelmann C. Gender and polypharmacotherapy in the elderly: a clinical challenge. In: Sex and Gender Differences in Pharmacology; 2013. p. 169–182.
Metadata
Title
Assessment of polypharmacy in elderly patients by using data from dispensed medications in community pharmacies: analysis of results by using different methods of estimation
Authors
Luciana Carla Chiapella
Jorgelina Montemarani Menna
María Eugenia Mamprin
Publication date
01-10-2018
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 5/2018
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-018-0663-3

Other articles of this Issue 5/2018

International Journal of Clinical Pharmacy 5/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.